The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
Travel, Accommodations, Expenses - Day One Biopharmaceuticals
 
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Research Funding - BioMed Valley Discoveries (Inst); Day One Biopharmaceuticals (Inst)
 
Consulting or Advisory Role - Lilly O.
LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Novartis
 
Lindsay Baker Kilburn
Employment - Kaiser Permanente (I)
Stock and Other Ownership Interests - Onconova Therapeutics (I)
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Blaze Bioscience (Inst); Bristol-Myers Squibb/Celgene (Inst); Day One Biopharmaceuticals (Inst); Epizyme (Inst); Helsinn Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); SpringWorks Therapeutics (Inst)
 
Erin Crotty
No Relationships to Disclose
 
Amy Amundson Smith
Consulting or Advisory Role - Day One Biopharmaceuticals
 
Sébastien Perreault
Leadership - Bayer
Stock and Other Ownership Interests - Day One Therapeutics; novocure
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Expert Testimony - Bayer
 
Andrea Flynn Franson
Consulting or Advisory Role - HERON
 
Nada Jabado
No Relationships to Disclose
 
Lindsey M. Hoffman
No Relationships to Disclose
 
Rene Schmidt
No Relationships to Disclose
 
Antoinette Y.N. Schouten-van Meeteren
No Relationships to Disclose
 
Astrid Sehestedt
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca
 
Enrico Opocher
Consulting or Advisory Role - Alexion Pharmaceuticals
Expert Testimony - Alexion Pharmaceuticals
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Pablo Hernáiz Driever
No Relationships to Disclose
 
Shivaram Avula
No Relationships to Disclose
 
David Simon Ziegler
Consulting or Advisory Role - Accendatech; Alexion Pharmaceuticals; Amgen; AstraZeneca/Merck; Bayer; Day One Biopharmaceuticals; FivePhusion; Norgine; Novartis
Research Funding - Accendatech (Inst)
Travel, Accommodations, Expenses - Bayer
 
Jiaheng Qiu
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Li-Pen Tsao
No Relationships to Disclose
 
Peter Manley
Employment - Day One Biopharmaceuticals; Repare Therapeutics
Stock and Other Ownership Interests - Repare Therapeutics
Travel, Accommodations, Expenses - Day One Biopharmaceuticals; Repare Therapeutics
 
Darren R. Hargrave
Honoraria - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Novartis; Roche/Genentech
Speakers' Bureau - Alexion Pharmaceuticals
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Day One Therapeutics; Epizyme; Novartis
 
Olaf Witt
No Relationships to Disclose